Healthcare Delivery Systems Research Paper
docx
keyboard_arrow_up
School
Walter State Community College *
*We aren’t endorsed by this school
Course
340
Subject
Medicine
Date
Jan 9, 2024
Type
docx
Pages
8
Uploaded by Hannah.Kameh12
A gap that has been detrimental to the delivery of healthcare and the aging population is the efficiency related to the rising cost of pharmaceuticals. As we dive into the world of pharmaceuticals we know that almost every American has had to pick up medication from the pharmacy for certain reasons as well as short-term reasons and in society today it is known that the majority of the aging population has medications that they have to take long term or for the rest of their lives. It is known that these medications for the aging population have increased in price greatly over the past few decades and are still increasing every day.
Health care has evolved over centuries, from diseases wiping out entire populations to those diseases being eradicated. The world in all has increased greatly in discovering new medicines, treatments, cures, and efficiency in care for patients. As we get into the modern age of
pharmaceuticals we see that medications have accelerated in cost, especially for seniors. The aging population puts more pressure on healthcare systems and increases the incidence of non-
communicable diseases. (Yeganeh, 2019) (1). This is damaging to the efficiency of healthcare for
elderly people because most of the aging population is on fixed incomes and is finding it difficult
to purchase medications that they need. The impacts that socioeconomic background has on the aging population's access to health care are encompassed by the centralization of the concept of healthy aging aka successful aging, “ the process of developing and maintaining functional ability that enables well-being in older age”. (World Health Organization, 2016) (2). While there are efforts to make healthy aging the new norm, the aging population are faced with many hardships such as financial problems resulting in inequities of resource distribution as well as positive health outcomes. Socioeconomic status such as wealth, higher education, and a successful job determines the efficiency of essential, affordable, and available access to healthcare in conjunction with the
benefit of healthy aging. Low socioeconomic status is associated with poorer health, reduced access to care, and increased mortality and morbidity as individuals age which in turn results in more medication prescribed at higher costs. (Ramsay, S.E,2008) (4)
The delivery of healthcare that is provided to the population is affected by the gap in efficiency due to the higher cost of pharmaceuticals, because of higher age, poverty, and the overall well-being of individuals. Efficiency is lacking in the delivery of healthcare to older adults who have limited healthcare budgets and limits in funding available in other areas where public investment is needed. Depending on the severity of the illness that an individual endures is all dependent on the innovation of medicinal needs which is a major reason why prescriptions and medicines have skyrocketed and will continue to increase as the person's disease worsens. (Vincent Rajkumar S.) (2020) (5). Unfortunately, society has created the saying you get what you
pay for and that goes for quality and effectiveness, that goes for many things, especially healthcare. If you are on a low fixed income and go to a lower-class clinic then you will get lower-class care. On the other hand, if you have more money and go to a high-class clinic then you will get high-class care and efficiency. Potential implications that could occur if this gap is not addressed is that healthcare will simply decrease in efficiency in relation to poor care. The possibility of slower innovation of newer prescriptions also plays a major role in this gap, if prices are lowered then it will take longer to discover and implement new and more effective medicines for the healthcare world. Health plans will continue to refuse routine coverage of high-cost drugs for individuals unless the individual's health worsens due to cheaper treatments. (Barlas S. (2015). (6). This can cause a
large amount of turmoil for many people and increased rates of mortality and morbidity will be on the rise if this gap keeps occurring.
As the aging population struggles with the rising costs of pharmaceuticals, there have been initiatives that address the gap that has been detrimental to the delivery of healthcare and the aging population is efficiency related to the rising cost of pharmaceuticals. Over decades, healthcare and pharmaceuticals have been on the rise and many people have become uninsured due to the ridiculously high prices to access healthcare and its benefits. Many are struggling, especially the aging population and the many health issues that have accrued over their life. After
retirement, most insurance policies are through the roof making it almost impossible to afford. According to an article from Health Affairs, there is a pressing need and opportunity for health reform that helps achieve better access, affordability, and equity. The initiative that this article provides is addressing the enormous costs of healthcare, better access to healthcare, and equity. This initiative prioritizes goals around five policies which include, expanding insurance coverage, accelerating the transition to value-based care, advancing home-based care, improving the affordability of drugs and other therapeutics, and developing a high-value workforce. The three main goals that are present in this initiative are access, affordability, and equity. Having these goals in mind aids in addressing this gap and creates the strive to be closer to eliminating this gap. (Shrank et al., 2021)
The circumstances around the development of this initiative were specifically that every American should have access to affordable healthcare. In 2016 there were a whopping 28.7 million people that were uninsured and is expected to rise to 37.2 million by 2028. The majority of these numbers are the aging population due to socioeconomic status, race, and type of health they are in. With the attempted help of the ACA or Affordable Care Act which aided in the drop of percentages of uninsured people, the percentages began to decrease year by year, however, with the help of the pandemic, those percentages increased to very high amounts which basically
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
- Access to all documents
- Unlimited textbook solutions
- 24/7 expert homework help
overran the ACA and its benefits and pharmaceutical prices went through the roof. ( Blumenthal D,2020)
The resources that were required to fund this existing initiative is the HHS which is the Department of Health and Human Services. The HHS should create alternative pathways to expand coverage in each state so healthcare and pharmaceuticals can be more affordable. Governors as well should be included in the funding to expand this ideal to expand the opportunity for Americans to have accessible and affordable healthcare. This initiative can reduce the costs of healthcare, pharmaceuticals, and the number of uninsured people in the aging population. With the rise of pharmaceutical prices, the FDA commissioner should expand on recent efforts to reduce barriers to generic and biosimilar development and market entry with the goal of increasing competition, improving access, and reducing prices. ( Augustine NR,2018). Alongside the benefits that this initiative could produce, there are unfortunate circumstances that the initiative is not meeting and requires improvement. With trial comes error and with many strains coming from the pandemic and stern policyholders it is going to take a lot of effort to make this reform. It will take a significant amount of discipline and attention to begin
a reform to more effective and affordable access to healthcare. Improvement needs to be made among certain institutions as well as governors and commissioners to provide the possibility of this reform. While attempting to achieve this meaningful change in the environment, will require significant resolve from policymakers and public support for difficult decisions, such as lower coverage for low-value services and technologies. (Shrank et al., 2021).
Overall, affordability for healthcare and pharmaceuticals is at an all-time high and is expected to increase over the next decade. However, with this initiative in place of attempting to create access, affordability, and equity, it is going to take a lot of attention and focus to overcome
something like this but with small progression and the willingness to accept small wins this reform will take place more and more every day.
Citations
1.
Yeganeh, H. (2019b). An analysis of emerging trends and transformations in Global Healthcare. International Journal of Health Governance
, 24
(2), 169–180. doi:10.1108/ijhg-02-2019-0012 2.
World Health Organization. (2016). Global strategy and action plan on aging and health (2016–2020). World Health Organization
.
3.
McMaughan, D. J., Oloruntoba, O., & Smith, M. L. (2020). Socioeconomic Status and Access to Healthcare: Interrelated Drivers for Healthy Aging. Frontiers in public health
, 8
, 231. https://doi.org/10.3389/fpubh.2020.00231
4.
Ramsay, S. E., Whincup, P. H., Morris, R. W., Lennon, L. T., & Wannamethee, S. G. (2008). Extent of social inequalities in disability in the elderly: results from a population-
based study of British men. Annals of Epidemiology
, 18
(12), 896–903. https://doi.org/10.1016/j.annepidem.2008.09.006
5.
Vincent Rajkumar S. (2020). The high cost of prescription drugs: causes and solutions. Blood cancer journal
, 10
(6), 71. https://doi.org/10.1038/s41408-020-0338-x
6.
Barlas S. (2015). States try to control Medicaid pharmaceutical costs: numerous, diverse cost pressures force myriad reform efforts. P & T: a peer-reviewed journal for formulary management
, 40
(4), 260–262.
7.
Kirzinger A, Kearney A, Brodie M . KFF Health Tracking Poll—February 2020: health care in the 2020 election [Internet]. San Francisco (CA): Henry J. Kaiser Family Foundation; 2020 Feb 21 [cited 2020 Dec 3]. Available from: https://www.kff.org/health-
reform/poll-finding/kff-health-tracking-poll-february-2020/
Google Scholar
8.
Webb Hooper M , Nápoles AM , Pérez-Stable EJ . COVID-19 and racial/ethnic
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
- Access to all documents
- Unlimited textbook solutions
- 24/7 expert homework help
disparities. JAMA. 2020;323(24):2466– 7 Crossref
, Medline
, Google Scholar
9.
Augustine NR, Madhavan G, Nass SJ, editors. Making medicines affordable: a national imperative [Internet]. Washington (DC): National Academies Press; 2018 [cited 2020 Dec
3]. Available from: https://www.nap.edu/catalog/24946/making-medicines-affordable-a-
national-imperative
Google Scholar
10. Verma S . CMS’s proposed rule on value-based purchasing for prescription drugs: new tools for negotiating prices for the next generation of therapies. Health Affairs Blog [blog on the Internet]. 2020 Jun 17 [cited 2020 Dec 3]. Available from: https://www.healthaffairs.org/do/10.1377/hblog20200617.728496/full/
Google Scholar
11. Blumenthal D, Collins SR, Fowler EJ. The Affordable Care Act at 10 years—its coverage
and access provisions. N Engl J Med. 2020;382(10):963– 9 Crossref
, Medline
, Google Scholar
12. Shrank, W. H., DeParle, N.-A., Gottlieb, S., Jain, S. H., Orszag, P., Powers, B. W., & Wilensky, G. R. (2021). Health costs and financing: Challenges and strategies for a new administration. Health Affairs
, 40
(2), 235–242. https://doi.org/10.1377/hlthaff.2020.01560
13.